Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines

Viruses - Switzerland
doi 10.3390/v4112711
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Advances and Future Challenges in Adenoviral Vector Pharmacology and Targeting

Current Gene Therapy
GeneticsDrug DiscoveryMolecular MedicineMolecular Biology
2011English

Yeast Surface-Displayed H5N1 Avian Influenza Vaccines

Journal of Immunology Research
MedicineAllergyImmunology
2016English

Adenoviral Vector Expressing Murine Β-Defensin 2 Enhances Immunogenicity of an Adenoviral Vector Based H5N1 Influenza Vaccine in Aged Mice

Virus Research
Cancer ResearchVirologyInfectious Diseases
2013English

H5N1 Influenza Vaccine Induces a Less Robust Neutralizing Antibody Response Than Seasonal Trivalent and H7N9 Influenza Vaccines

npj Vaccines
Infectious DiseasesImmunologyPharmacology
2017English

Vaccines for an Influenza Pandemic: Scientific and Political Challenges

Influenza and other Respiratory Viruses
EnvironmentalPublic HealthEpidemiologyPulmonaryInfectious DiseasesRespiratory MedicineOccupational Health
2007English

Challenges and Future in Vaccines, Drug Development, and Immunomodulatory Therapy

Annals of the American Thoracic Society
PulmonaryRespiratory Medicine
2014English

Evaluation of Recombinant Influenza Virus-Simian Immunodeficiency Virus Vaccines in Macaques

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2009English

Recombinant Parainfluenza Virus 5 Expressing Hemagglutinin of Influenza a Virus H5N1 Protected Mice Against Lethal Highly Pathogenic Avian Influenza Virus H5N1 Challenge

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2012English

Inactivated Influenza Virus Vaccines: The Future of TIV and QIV

Current Opinion in Virology
Virology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy